Transthyretin Amyloidosis: CRISPR-Cas9 Technology Shows Results in a Single Treatment

In August of 2021, Intellia Therapeutics of Cambridge and its partner Regeneron Pharmaceuticals published a study reported in the Boston Globe, showing results of a single treatment using CRISPR-Cas9 technology.…

Continue Reading Transthyretin Amyloidosis: CRISPR-Cas9 Technology Shows Results in a Single Treatment
A New Program Helps with Medical Costs Associated with Cold Agglutinin Disease (CAD)
source: pixabay.com

A New Program Helps with Medical Costs Associated with Cold Agglutinin Disease (CAD)

Since its founding in 2009, The Assistance Fund (TAF), an independent charitable patient assistance organization, has helped patients and families within the rare disease and chronic illness sphere with financial…

Continue Reading A New Program Helps with Medical Costs Associated with Cold Agglutinin Disease (CAD)
Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates
source: pixabay.com

Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates

Unintended weight loss is a symptom associated with many different forms of cancer. But what can this weight loss tell researchers about the patients and their outcomes? Healio shares a…

Continue Reading Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates
FDA Approves ZTALMY for CDKL5 Deficiency Disorder
source: pixabay.com

FDA Approves ZTALMY for CDKL5 Deficiency Disorder

Until recently, patients with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) did not have an FDA-approved treatment option. This all changed when the regulatory agency granted approval to ZTALMY, also…

Continue Reading FDA Approves ZTALMY for CDKL5 Deficiency Disorder
Medical Professionals Discuss Guidelines for Psoriatic Arthritis
Aymanjed / Pixabay

Medical Professionals Discuss Guidelines for Psoriatic Arthritis

Recently, two medical professionals were interviewed where they discussed their recommendations for the guidelines pertaining to managing psoriatic arthritis. Psoriatic Arthritis Psoriatic arthritis is a type of inflammatory arthritis that…

Continue Reading Medical Professionals Discuss Guidelines for Psoriatic Arthritis
HCU Network America Partners With RARE X to Create a Patient Registry
source: pixabay.com

HCU Network America Partners With RARE X to Create a Patient Registry

Patient Worthy partner HCU Network America and RARE X, a rare disease patient data service organization, have recently partnered in order to create a registry of patients living with homocystinuria,…

Continue Reading HCU Network America Partners With RARE X to Create a Patient Registry
InformedDNA, Foundation Fighting Blindness Partnership Will Screen Patients for Usher Syndrome, RP Clinical Trials
source: pixabay.com

InformedDNA, Foundation Fighting Blindness Partnership Will Screen Patients for Usher Syndrome, RP Clinical Trials

ProQR Therapeutics is working to develop unique therapeutic solutions for genetic eye diseases. Currently, the company is evaluating its therapeutic candidate ultevursen within the Phase 2/3 Sirius and Celeste clinical trials; you can read…

Continue Reading InformedDNA, Foundation Fighting Blindness Partnership Will Screen Patients for Usher Syndrome, RP Clinical Trials
First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
https://unsplash.com/photos/tV-RX0beDp8

First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia

Each year, an estimated 11,000 people across the globe are diagnosed with relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (LBL). However, there is only one…

Continue Reading First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
Achieving Optimal Patient Outcomes in Chronic Pain Management Across Multiple Treatments: Part Two
source: pixabay.com

Achieving Optimal Patient Outcomes in Chronic Pain Management Across Multiple Treatments: Part Two

Written by Sumeet Maniar, CEO, WellBrain Continued From Part One Monitoring Adherence to Non-Opioid Treatments Given the links between chronic pain and mental health, a large part of managing chronic…

Continue Reading Achieving Optimal Patient Outcomes in Chronic Pain Management Across Multiple Treatments: Part Two
Study of the Week: Early GI Cancer Screening is Recommended for Primary Immunodeficiency Patients
source: pixabay.com

Study of the Week: Early GI Cancer Screening is Recommended for Primary Immunodeficiency Patients

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Early GI Cancer Screening is Recommended for Primary Immunodeficiency Patients